Suppression of Natural Killer Cells by Sorafenib Contributes to Prometastatic Effects in Hepatocellular Carcinoma

• Qiang-Bo Zhang ,

  Contributed equally to this work with: Qiang-Bo Zhang, Hui-Chuan Sun, Ke-Zhi Zhang

  Affiliation Liver Cancer Institute and Zhongshan Hospital, Fudan University, Key Laboratory for Carcinogenesis and Cancer Invasion, The Chinese Ministry of Education, Shanghai, People’s Republic of China

  ⨯
• Hui-Chuan Sun ,

  Contributed equally to this work with: Qiang-Bo Zhang, Hui-Chuan Sun, Ke-Zhi Zhang

  Affiliation Liver Cancer Institute and Zhongshan Hospital, Fudan University, Key Laboratory for Carcinogenesis and Cancer Invasion, The Chinese Ministry of Education, Shanghai, People’s Republic of China

  ⨯
• Ke-Zhi Zhang ,

  Contributed equally to this work with: Qiang-Bo Zhang, Hui-Chuan Sun, Ke-Zhi Zhang

  Affiliation Liver Cancer Institute and Zhongshan Hospital, Fudan University, Key Laboratory for Carcinogenesis and Cancer Invasion, The Chinese Ministry of Education, Shanghai, People’s Republic of China

  ⨯
• Qing-An Jia,

  Affiliation Liver Cancer Institute and Zhongshan Hospital, Fudan University, Key Laboratory for Carcinogenesis and Cancer Invasion, The Chinese Ministry of Education, Shanghai, People’s Republic of China

  ⨯
• Yang Bu,

  Affiliation Liver Cancer Institute and Zhongshan Hospital, Fudan University, Key Laboratory for Carcinogenesis and Cancer Invasion, The Chinese Ministry of Education, Shanghai, People’s Republic of China

  ⨯
• Miao Wang,

  Affiliation Liver Cancer Institute and Zhongshan Hospital, Fudan University, Key Laboratory for Carcinogenesis and Cancer Invasion, The Chinese Ministry of Education, Shanghai, People’s Republic of China

  ⨯
• Zong-Tao Chai,

  Affiliation Liver Cancer Institute and Zhongshan Hospital, Fudan University, Key Laboratory for Carcinogenesis and Cancer Invasion, The Chinese Ministry of Education, Shanghai, People’s Republic of China

  ⨯
• Quan-Bao Zhang,

  Affiliation Liver Cancer Institute and Zhongshan Hospital, Fudan University, Key Laboratory for Carcinogenesis and Cancer Invasion, The Chinese Ministry of Education, Shanghai, People’s Republic of China

  ⨯
• Wen-Quan Wang,

  Affiliation Liver Cancer Institute and Zhongshan Hospital, Fudan University, Key Laboratory for Carcinogenesis and Cancer Invasion, The Chinese Ministry of Education, Shanghai, People’s Republic of China

  ⨯
• Ling-Qun Kong,

  Affiliation Liver Cancer Institute and Zhongshan Hospital, Fudan University, Key Laboratory for Carcinogenesis and Cancer Invasion, The Chinese Ministry of Education, Shanghai, People’s Republic of China

  ⨯
• Xiao-dong Zhu,

  Affiliation Liver Cancer Institute and Zhongshan Hospital, Fudan University, Key Laboratory for Carcinogenesis and Cancer Invasion, The Chinese Ministry of Education, Shanghai, People’s Republic of China

  ⨯
• Lu Lu,

  Affiliation Liver Cancer Institute and Zhongshan Hospital, Fudan University, Key Laboratory for Carcinogenesis and Cancer Invasion, The Chinese Ministry of Education, Shanghai, People’s Republic of China

  ⨯
• Wei-Zhong Wu,

  Affiliation Liver Cancer Institute and Zhongshan Hospital, Fudan University, Key Laboratory for Carcinogenesis and Cancer Invasion, The Chinese Ministry of Education, Shanghai, People’s Republic of China

  ⨯
• Lu Wang,

  Affiliation Liver Cancer Institute and Zhongshan Hospital, Fudan University, Key Laboratory for Carcinogenesis and Cancer Invasion, The Chinese Ministry of Education, Shanghai, People’s Republic of China

  ⨯
• Zhao-You Tang

  * E-mail: zytang88@163.com

  Affiliation Liver Cancer Institute and Zhongshan Hospital, Fudan University, Key Laboratory for Carcinogenesis and Cancer Invasion, The Chinese Ministry of Education, Shanghai, People’s Republic of China

  ⨯